Sesen Bio Total Non Current Liabilities 2011-2026 | SESN

Annual Total Non Current Liabilities Sesen Bio

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	57.5 M	114 M	133 M	61.2 M	52.3 M	61.4 M	10.3 M	13 M	3.54 M	1.94 M	594 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
133 M	594 K	46.2 M

Quarterly Total Non Current Liabilities Sesen Bio

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	1.8 M	44.6 M	57.5 M	62.1 M	57.5 M	-	114 M	114 M	114 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
114 M	1.8 M	70.7 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	69.4 M	$ 21.65	-	$ 1.01 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptorum Group Limited APM	2.21 M	$ 0.9	-0.18 %	$ 6.62 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 22.3	-	$ 3.7 B	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	38.2 M	-	-	$ 35.4 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Fennec Pharmaceuticals FENC	24.6 M	$ 6.85	-	$ 196 M	USA
ChromaDex Corporation CDXC	5.46 M	-	-0.88 %	$ 598 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Galectin Therapeutics GALT	52 K	$ 2.37	-	$ 151 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Greenwich LifeSciences GLSI	9.5 M	$ 23.99	-	$ 312 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	341 M	$ 102.06	-	$ 27.2 B	Germany
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Heron Therapeutics HRTX	14.6 M	$ 1.19	-	$ 198 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.1	-	$ 438 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 23.42	-	$ 2.98 B	USA
ImmuCell Corporation ICCC	11.5 M	$ 8.25	-	$ 74.5 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.42	-	$ 378 M	Britain
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Inventiva S.A. IVA	13.8 M	$ 5.13	-	$ 138 M	France
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.92	-	$ 4.81 M	Israel
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Kamada Ltd. KMDA	7.06 M	$ 8.2	-	$ 260 M	Israel